Skip to content

China Colorectal Cancer Screening Trial 1 (C-Cost1): colonoscopy versus FIT versus FIT plus blood test in the average risk population

China Colorectal Cancer Screening Trial 1 (C-Cost1): colonoscopy versus FIT versus FIT plus blood test in the average risk population

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122324
Enrollment
Unknown
Registered
2026-04-12
Start date
2025-08-08
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer, advanced colorectal adenoma

Interventions

Colonoscopy Screening Group:Colonoscopy Screening
FIT group:FIT Screening
FIT plus blood test group:FIT?blood test

Sponsors

The second affiliated hospital of Zhejiang University school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Age: 45-74 years old; 2.In good general condition, with normal mental state and voluntarily signing the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Personal history of colorectal cancer or precancerous lesions; 2. History of previous colon resection surgery; 3. Diagnosed with cancer before enrollment or currently receiving any cancer-related treatment; 4. Having received colonoscopy, flexible sigmoidoscopy, CT colonography and other examinations within the past 5 years; 5. Having received FIT or FIT-sDNA or cfDNA test within the past 1 year; 6. Symptomatic lower gastrointestinal diseases or symptoms suggesting the need for diagnostic colonoscopy for confirmation; 7. Accompanied by severe diseases that are not suitable for colorectal cancer screening.

Design outcomes

Primary

MeasureTime frame
Mortality rate of colorectal cancer at 10 years;

Secondary

MeasureTime frame
Incidence rate of colorectal cancer at 10 years;Proportion of colorectal cancer at different stages;Total cost and cost per detected lesion;Quality of life;Detection rate of advanced colorectal neoplasms (advanced adenomas + colorectal cancer);Population compliance rate;Incremental cost-effectiveness ratio;

Countries

China

Contacts

Public ContactKefeng Ding

The second affiliated hospital of Zhejiang University school of medicine

dingkefeng@zju.edu.cn+86 13906504783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026